Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Diversity Enrichment: US FDA Guidance Suggests Sponsors May Need To Overenroll Key Groups
Jun 26 2024
•
By
Sarah Karlin-Smith
While greater than proportional enrollment may be necessary, the FDA will not conduct statistical testing on population subgroups. • Source: Shutterstock
More from Diversity & Inclusion
More from ESG